Paul Danner serves as the Chairman and Chief Executive Officer of Pepex Biomedical, Inc., a medical device contract development organization specializing in electrochemical biosensors. With a robust leadership portfolio, Paul also holds roles such as Chief Financial and Administrative Officer at Authvia, Executive Director and Audit Committee Chairman at Sharps Technology, Inc., and Chairman of the Board at CB Scientific, Inc. Additionally, Paul is the Managing Director of Destiny Partners Worldwide and has been on the Board of Directors for RDE, Inc. and the Greater Jacksonville Area USO. Previously, Paul was Chairman and CEO of Alliance MMA, Inc., and CEO of China Crescent. A retired Captain of the United States Navy, Paul boasts extensive military experience as a Naval Aviator and Aerospace Engineering Duty Officer. Paul Danner earned an MBA from Old Dominion University and a Bachelor of Science in Business Finance from Colorado State University, among other educational credentials.
This person is not in any teams
This person is not in any offices
Sharps Technology, Inc.
Sharps Technology is an innovative medical device company introducing a new patented best in class single use safety syringe. Their “game changing technology” programs are designed to eliminate an estimated 2 million accidental infectious needle sticks each year. PROMESIA™ is poised to help change the risk of exposure to the 14 billion injectionsgiven each year.